Summit receives investment from U. of Colorado Anschutz Medical Campus CDI Fund
AURORA -- Summit Biolabs, an early-stage molecular diagnostics company specializing in saliva liquid-biopsy tests for COVID-19 and head and neck cancer, announced it received funding from... Read More
Thursday November 19, 2020
Summit Biolabs, Center for Personalized Medicine to develop saliva tests for COVID, head & neck cancer
AURORA -- Summit Biolabs, Inc. , an early-stage molecular diagnostics company specializing in saliva-based testing for COVID-19 and head neck cancer, and the Colorado Center for Personalized... Read More
Thursday October 15, 2020
Impressio and MedShape awarded grant from National Science Foundation to develop joint replacement device
AURORA -- Impressio Inc. and Atlanta-based MedShape Inc. have been awardeda National Science Foundation (NSF) Small Business Innovation Research (SBIR)grantfor $250,000to conduct research and... Read More
Wednesday July 29, 2020
Neurexis Therapeutics awarded $250K Colorado Advanced Industries Accelerator Grant
AURORA -- Neurexis Therapeutics, Inc. announced it has been approved for funding as part of the Colorado Office of Economic Development and International Trade’s (OEDIT) Advanced Industries... Read More
Wednesday June 3, 2020
Regeneron and Colorado Center for Personalized Medicine announce major new human genetics research collaboration
AURORA -- New York-based Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and the Colorado Center for Personalized Medicine ( CCPM) at the University of Colorado Anschutz Medical Campus today... Read More
Tuesday May 12, 2020
Neurexis Therapeutics created to develop drug to tackle cerebral ischemia
AURORA -- VIC Technology Venture Development, LLC (VIC) announced the formation of Neurexis Therapeutics, Inc. to develop a new medication for the prevention of brain damage following ischemic... Read More
Monday April 27, 2020
Greffex completes COVID-19 vaccine, prepares for FDA animal testing
HOUSTON/AURORA -- Texas-based genetic engineering company Greffex, Inc. announced it has completed development of a Covid-19 vaccine and is ready to move on to animal testing as required by the U.S.... Read More
Thursday March 12, 2020
Women in CyberSecurity 2020 conference set for March 13-14 in Aurora
AURORA -- Women in CyberSecurity (WiCyS) is hosting its seventh annual conference, March 13-14, at the Gaylord Rockies Resort and Convention Center in Aurora. The event supports its mission to... Read More
Thursday February 20, 2020
IN Sponsors
Browse
Entrepreneurial by Nature
